https://www.pharmanow.live/latest-news/cosette-pharmaceuticals-appoints-andrew-adams-vp-supply-chain-sourcing 2026-09-10T22:35:00+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Cosette Pharmaceuticals Appoints Andrew Adams as Vice President of Supply Chain and Sourcing Cosette https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/268da35b-723a-49e3-b31d-9018babeb6ed/e04703f1-6924-4272-9185-404904f8ea07.png https://www.pharmanow.live/latest-news/abbvie-atogepant-phase-3-luna-menstrual-migraine-results 2026-09-10T22:36:01+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 AbbVie Achieves Phase 3 Primary and All Secondary Endpoints for Atogepant in Menstrual Migraine AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/268da35b-723a-49e3-b31d-9018babeb6ed/31e3f99e-9d2a-4e34-a9d1-d6fafdcc0499.png https://www.pharmanow.live/latest-news/fda-removes-paba-trolamine-salicylate-otc-sunscreen-monograph-2026 2026-09-10T22:35:25+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA Removes PABA and Trolamine Salicylate from OTC Sunscreen Monograph in September 2026 Final Order https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/268da35b-723a-49e3-b31d-9018babeb6ed/f2a12319-a354-4981-a918-cb97b4f9545f.png https://www.pharmanow.live/latest-news/roche-fda-priority-review-enspryng-sbla-mogad-january-2027 2026-09-10T22:32:42+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Roche Gains FDA Priority Review for Enspryng sBLA in MOGAD with Decision Due January 2027 Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20f9ef1f-7f69-43ae-b9ef-c44f93b1a24b/3139a16c-6425-4c51-a932-04999dc658a9.png https://www.pharmanow.live/latest-news/medicus-pharma-skinject-phase-2-csr-200mcg-dose-basal-cell-carcinoma 2026-09-10T22:33:10+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Medicus Pharma Identifies 200 µg D-MNA Dose as Lead in Phase 2 SkinJect CSR for Basal Cell Carcinoma Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20f9ef1f-7f69-43ae-b9ef-c44f93b1a24b/a7fdb304-9e23-452a-9cef-0746c1f864fc.png https://www.pharmanow.live/latest-news/sarborg-quantum-computing-signature-intelligence-neuropsychiatric-drug-discovery 2026-09-10T22:34:05+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Sarborg Applies Quantum Computing and Signature Intelligence Models to Neuropsychiatric Drug Discovery Sarborg https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20f9ef1f-7f69-43ae-b9ef-c44f93b1a24b/539c9023-652d-499f-b4b5-8daee0bfd896.png https://www.pharmanow.live/latest-news/ritedose-appoints-carolyn-berg-vice-president-strategic-growth 2026-09-10T22:31:42+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Ritedose Appoints Carolyn Berg as Vice President of Strategic Growth in Sterile BFS Expansion Ritedose https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/1d5f4368-063b-4fb9-9364-e6cf4fe049c8 https://www.pharmanow.live/latest-news/fda-ich-m3r2-nonclinical-safety-studies-clinical-trial-authorization 2026-09-10T13:06:34+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA Resurfaces ICH M3(R2) Guidance on Nonclinical Safety Studies FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ich-m3r2-nonclinical-safety-studies20260910130628.webp https://www.pharmanow.live/latest-news/novo-nordisk-fda-approval-rebinyn-recombinant-glycopegylated-factor-ix-hemophilia-b 2026-09-10T13:11:14+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Novo Nordisk Rebinyn Obtains Fda Approvals For Hemophilia B Cases Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-fda-approval-rebinyn-hemophilia-b20260910131100.webp https://www.pharmanow.live/latest-news/fda-otat-gene-therapy-cmc-town-hall-series-advanced-therapy-manufacturers 2026-09-10T10:29:37+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA OTAT Launches Gene Therapy CMC Town Hall Series FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/471f2524-97bb-4616-9ac3-71e7ca1f298d/7ada22f5-ddf1-4307-9543-08d93876e8a8.png https://www.pharmanow.live/latest-news/proqr-therapeutics-doses-first-participant-phase-1-ax-0811-rna-editing 2026-09-10T13:24:34+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 ProQR Therapeutics Doses First Participant in Phase 1 Study of AI-Discovered RNA Editing Candidate AX-0811 ProQR https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/proqr-therapeutics-phase-1-ax-0811-rna-editing20260910132424.webp https://www.pharmanow.live/latest-news/propanc-biopharma-phase-1b-first-in-human-prp-february-2027 2026-09-10T13:26:35+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Propanc Biopharma Targets February 2027 First-in-Human Phase 1b Study of PRP in Solid Tumors Propanc https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/propanc-biopharma-phase-1b-prp-202720260910132631.webp https://www.pharmanow.live/latest-news/cellipont-bioservices-xiogenix-fill-finish-white-paper-cell-therapy-manufacturing 2026-09-10T13:33:45+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Cellipont Bioservices and Xiogenix Publish Fill-Finish White Paper for Scalable Cell Therapy Manufacturing Cellipont https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cellipont-bioservices-xiogenix-fill-finish-white-paper20260910133334.webp https://www.pharmanow.live/latest-news/bayer-fda-accelerated-approval-sevabertinib-her2-mutant-nsclc-first-line 2026-09-10T13:38:25+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Bayer Gains FDA Accelerated Approval for Sevabertinib in First-Line HER2-Mutant NSCLC Bayer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bayer-fda-accelerated-approval-sevabertinib-nsclc20260910133808.webp https://www.pharmanow.live/latest-news/cdsco-risk-based-drug-regulation-compliance-burden-2026 2026-09-10T13:43:35+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 CDSCO Shifts To Risk-Based Drug Approvals To Ease Compliance CDSCO https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cdsco-risk-based-drug-regulation-compliance20260910134329.webp https://www.pharmanow.live/latest-news/just-evotec-biologics-jst-018-orthopoxvirus-phase-1-dow-contract 2026-09-10T13:51:26+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Just Evotec Advances JST-018 Orthopoxvirus Cocktail To Phase 1 Just Evotec https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/just-evotec-biologics-jst-018-orthopoxvirus20260910135115.webp https://www.pharmanow.live/latest-news/probiogen-transgene-expand-virus-based-therapy-manufacturing-collaboration 2026-09-10T13:56:46+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 ProBioGen & Transgene Expand Virus-Based Therapy Manufacturing ProBioGen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/probiogen-transgene-virus-based-therapy-manufacturing20260910135634.webp https://www.pharmanow.live/latest-news/onyx-scientific-expands-uk-gmp-api-capacity-15-million-investment 2026-09-10T14:06:56+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Onyx Scientific Expands UK API Capacity With £1.5M Investment Onyx https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/onyx-scientific-expands-uk-gmp-api-capacity20260910140646.webp https://www.pharmanow.live/latest-news/rezubio-doses-first-patients-phase-i-trial-inhaled-rz-520 2026-09-10T14:11:26+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Rezubio Begins Phase I Trial Of Inhaled Respiratory Drug RZ-520 Rezubio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rezubio-phase-i-inhaled-rz-52020260910141122.webp https://www.pharmanow.live/latest-news/elix-axcelead-ddp-collaborative-research-agreement-targeted-protein-degraders 2026-09-10T14:19:07+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Elix & Axcelead Partner to Accelerate Protein Degrader Discovery Elix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/elix-axcelead-collaboration-targeted-protein-degraders20260910141858.webp https://www.pharmanow.live/latest-news/neurizon-appoints-dr-chris-bremer-ceo 2026-09-10T14:14:37+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Neurizon Appoints Dr. Chris Bremer As CEO To Lead Strategy Neurizon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/neurizon-appoints-dr-chris-bremer-ceo20260910141423.webp https://www.pharmanow.live/latest-news/inhibitor-therapeutics-itraconazole-bccns-revised-fda-regulatory-strategy 2026-09-10T14:23:57+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Inhibitor Therapeutics Updates FDA Strategy for Itraconazole Inhibitor Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/inhibitor-therapeutics-itraconazole-bccns-fda-strategy20260910142344.webp https://www.pharmanow.live/latest-news/assembly-biosciences-exercises-us-profit-share-option-gilead-hsv-helicase-primase-inhibitor 2026-09-10T14:41:08+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Assembly Bio Exercises 40% US Profit Option With Gilead On HSV Assembly Bio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/assembly-biosciences-profit-share-gilead-hsv-inhibitor20260910144100.webp https://www.pharmanow.live/latest-news/inventiva-presents-five-lanifibranor-abstracts-paris-mash-2026 2026-09-09T12:15:15+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Inventiva Presents Five Lanifibranor Abstracts At Paris MASH 2026 Inventiva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/8d23e27e-0d1c-4f01-b926-d68c81a08696.png https://www.pharmanow.live/latest-news/fda-ddt-qualification-metrics-update-september-2026 2026-09-09T12:13:22+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Updates DDT Metrics: 160 Projects Active As Of July 2026 FDA Updates https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/e23d85ff-56de-4ba0-b7d1-0d515985af3b.png https://www.pharmanow.live/latest-news/fda-cber-blood-products-approval-pathways-bla-nda-pma-510k 2026-09-09T12:18:17+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Maps 4 Approval Pathways For Blood Products FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/0a872d01-50f4-4e09-b8f9-6ffae647b85e.png https://www.pharmanow.live/latest-news/fda-clarifies-cber-jurisdiction-nda-anda-blood-products 2026-09-09T12:21:05+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Clarifies CBER Control Over Blood NDA And ANDA Paths FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/45793206-9fe9-47a0-9e99-064c0bb1560d.png https://www.pharmanow.live/latest-news/fda-updates-general-biologics-guidance-library-cmc-gmp-documents 2026-09-09T12:23:39+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Updates Biologics Library With CMC And GMP Reference Docs FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/64420afd-aa9d-4e9f-bd65-b5747e89bf14.png